Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. SCFAs raise intracellular calcium in identified colonic L cells. A: Mixed colonic cultures were loaded with fura2-AM. Pseudocolor images of fura2 340:380 nm fluorescence ratio (reflecting [Ca2+]i) shown prior to (basal) and during the application of propionate (1 mmol/L), and after washing with saline. B: Identification of an L cell in the field of view shown in A identified by the fluorescence of Venus (475 nm excitation). C: A representative response of an L and a non–L cell recorded as in A. D: Mean calcium changes in L cells (filled bars) and non–L cells (open bars) after the addition of acetate (1 mmol/L), propionate (1 mmol/L), or CFMB (30 μmol/L) as indicated. Ratios (340:380) in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the test compound. Data represent the means ± SEM of the number of cells indicated above each bar. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with baseline and ##P < 0.01 and ###P < 0.001 compared with non–L cells by Student t test. (A high-quality digital representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/c242c8ac43cc4c669f03082b05300a60/short-chain-fatty-acids-stimulate-glucagon-like-peptide-1-secretion-via-the-g-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [276]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in rodents show that the administration of prebiotics that influences a shift in the gut microbiome toward increased production of butyrate has beneficial effects associated with higher levels of GLP-1 (193–195), as well as hypothalamic expression of pro-opiomelanocortin (196), thereby influencing the hunger-satiety cycle.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [193]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can stimulate the secretion of GLP-1 and PYY through the FFAR2 and, to a lesser extent, the FFAR3 receptor (Lin et al., 2012;Psichas et al., 2015;Tolhurst et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Tolhurst et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, SCFA can stimulate the release of GLP-1 in vitro and in vivo dependently of the FFA receptor 2 (Figure 1) [237].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [237]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 8×
“Secreted and cellular GLP-1 was extracted as previously described (24), and active GLP-1 was quantified by ELISA (Millipore).”
MethodInfluentialSelf-citationXiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Cited by
Items 201–300 of 1,015
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M., & Koga, Y. (2017) · Scientific Reports · doi:10.1038/srep43522 · Cited by 225
Deehan, E. C., Duar, R. M., Armet, A. M., Perez-Muñoz, M. E., Jin, M., & Walter, J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0019-2017 · Cited by 221
Yan, F., Li, N., Shi, J., Li, H., Yue, Y., Jiao, W., Wang, N., Song, Y., Huo, G., & Li, B. (2019) · Food & Function · doi:10.1039/c9fo01062a · Cited by 222
Mechanisms Linking the Gut Microbiome and Glucose Metabolism
Utzschneider, K. M., Kratz, M., Damman, C. J., & Hullarg, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4251 · Cited by 214
Zhong, H., Penders, J., Shi, Z., Ren, H., Cai, K., Fang, C., Ding, Q., Thijs, C., Blaak, E. E., Stehouwer, C. D. A., et al. (2019) · Microbiome · doi:10.1186/s40168-018-0608-z · Cited by 220
GPR43 Potentiates β-Cell Function in Obesity
McNelis, J. C., Lee, Y. S., Mayoral, R., van der Kant, R., Johnson, A. M. F., Wollam, J., & Olefsky, J. M. (2015) · Diabetes · doi:10.2337/db14-1938 · Cited by 224
Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota
Bauer, P. V., Hamr, S. C., & Duca, F. A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2083-z · Cited by 216
Lee, S., Keirsey, K. I., Kirkland, R., Grunewald, Z. I., Fischer, J. G., & de La Serre, C. B. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxx027 · Cited by 222
Zhou, D., Chen, Y.-W., Zhao, Z.-H., Yang, R.-X., Xin, F.-Z., Liu, X.-L., Pan, Q., Zhou, H., & Fan, J.-G. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0183-1 · Cited by 217
Spiljar, M., Merkler, D., & Trajkovski, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01353 · Cited by 219
Short-chain fatty acids suppress food intake by activating vagal afferent neurons
Goswami, C., Iwasaki, Y., & Yada, T. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.009 · Cited by 216
Sasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 204
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
The gut microbiome: a core regulator of metabolism
Fujisaka, S., Watanabe, Y., & Tobe, K. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0111 · Cited by 203
Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes
Jyoti, & Dey, P. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00066-1 · Cited by 191
Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Zhang, L., Chu, J., Hao, W., Zhang, J., Li, H., Yang, C., Yang, J., Chen, X., & Wang, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/5110276 · Cited by 201
Cheng, J., Hu, H., Ju, Y., Liu, J., Wang, M., Liu, B., & Zhang, Y. (2024) · General Psychiatry · doi:10.1136/gpsych-2023-101374 · Cited by 196
Gut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis
Nay, K., Jollet, M., Goustard, B., Baati, N., Vernus, B., Pontones, M., Lefeuvre-Orfila, L., Bendavid, C., Rué, O., Mariadassou, M., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00521.2018 · Cited by 215
Nutritional Signaling via Free Fatty Acid Receptors
Miyamoto, J., Hasegawa, S., Kasubuchi, M., Ichimura, A., Nakajima, A., & Kimura, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040450 · Cited by 214
Obesity, diabetes, and the gut microbiome: an updated review
Singer-Englar, T., Barlow, G., & Mathur, R. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1543023 · Cited by 214
Impact of Gut Microbiota on Host Glycemic Control
Gérard, C., & Vidal, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00029 · Cited by 209
Zhang, S., Zhao, J., Xie, F., He, H., Johnston, L. J., Dai, X., Wu, C., & Ma, X. (2021) · Obesity Reviews · doi:10.1111/obr.13316 · Cited by 209
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q.-H., & Di Ciaula, A. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 211
The metabolic impact of small intestinal nutrient sensing
Duca, F. A., Waise, T. M. Z., Peppler, W. T., & Lam, T. K. T. (2021) · Nature Communications · doi:10.1038/s41467-021-21235-y · Cited by 205
Zhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114295 · Cited by 198
Schéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., & Jansson, J.-O. (2013) · Endocrinology · doi:10.1210/en.2012-2151 · Cited by 209
Li, X., Watanabe, K., & Kimura, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01882 · Cited by 205
GPR43/FFA2: physiopathological relevance and therapeutic prospects
Bindels, L. B., Dewulf, E. M., & Delzenne, N. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.02.002 · Cited by 208
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Picu, A., Petcu, L., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 210
Hwang, I., Park, Y. J., Kim, Y., Kim, Y. N., Ka, S., Lee, H. Y., Seong, J. K., Seok, Y., & Kim, J. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-265983 · Cited by 206
Hjorth, M. F., Roager, H. M., Larsen, T. M., Poulsen, S. K., Licht, T. R., Bahl, M. I., Zohar, Y., & Astrup, A. (2018) · International Journal of Obesity · doi:10.1038/ijo.2017.220 · Cited by 207
Gut Microbiome and Obesity: A Plausible Explanation for Obesity
Sanmiguel, C., Gupta, A., & Mayer, E. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0152-0 · Cited by 204
Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer
Carretta, M. D., Quiroga, J., López, R., Hidalgo, M. A., & Burgos, R. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.662739 · Cited by 197
Dalile, B., Vervliet, B., Bergonzelli, G., Verbeke, K., & Van Oudenhove, L. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0732-x · Cited by 201
SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
Deng, M., Qu, F., Chen, L., Liu, C., Zhang, M., Ren, F., Guo, H., Zhang, H., Ge, S., Wu, C., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0018 · Cited by 200
Zhao, C., Yang, C., Wai, S. T. C., Zhang, Y., P. Portillo, M., Paoli, P., Wu, Y., San Cheang, W., Liu, B., Carpéné, C., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1501658 · Cited by 199
The role of the gut microbiota in metabolic health
Janssen, A. W. F., & Kersten, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-269514 · Cited by 197
Payne, A. N., Chassard, C., & Lacroix, C. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01009.x · Cited by 199
The L-cell in nutritional sensing and the regulation of appetite
Spreckley, E. (2015) · Frontiers in Nutrition · doi:10.3389/fnut.2015.00023 · Cited by 198
Molecular link between dietary fibre, gut microbiota and health
Kumar, J., Rani, K., & Datt, C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05611-3 · Cited by 192
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Song, P., Onishi, A., Koepsell, H., & Vallon, V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1168808 · Cited by 194
Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders
Horn, J., Mayer, D. E., Chen, S., & Mayer, E. A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01922-0 · Cited by 193
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Lyu, M., Wang, Y.-F., Fan, G.-W., Wang, X.-Y., Xu, S.-Y., & Zhu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02146 · Cited by 192
The gut microbiota and its interactions with cardiovascular disease
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q., & Cai, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13524 · Cited by 186
Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells
Marinelli, L., Martin-Gallausiaux, C., Bourhis, J.-M., Béguet-Crespel, F., Blottière, H. M., & Lapaque, N. (2019) · Scientific Reports · doi:10.1038/s41598-018-37019-2 · Cited by 181
O'Keefe, S. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30257-2 · Cited by 186
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion
Priyadarshini, M., Villa, S. R., Fuller, M., Wicksteed, B., Mackay, C. R., Alquier, T., Poitout, V., Mancebo, H., Mirmira, R. G., Gilchrist, A., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1007 · Cited by 187
Luan, H., Wang, X., & Cai, Z. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21553 · Cited by 187
The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity
Bliss, E. S., & Whiteside, E. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00900 · Cited by 186
Carbohydrates and the human gut microbiota
Chassard, C., & Lacroix, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283619e63 · Cited by 188
Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
Salgaço, M. K., Oliveira, L. G. S., Costa, G. N., Bianchi, F., & Sivieri, K. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10156-y · Cited by 182
Wang, Z., Zhang, X., Zhu, L., Yang, X., He, F., Wang, T., Bao, T., Lu, H., Wang, H., & Yang, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106062 · Cited by 184
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170042 · Cited by 164
A Critical Look at Prebiotics Within the Dietary Fiber Concept
Verspreet, J., Damen, B., Broekaert, W. F., Verbeke, K., Delcour, J. A., & Courtin, C. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-081315-032749 · Cited by 185
Gut microbiome and its role in cardiovascular diseases
Ahmadmehrabi, S., & Tang, W. H. W. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000445 · Cited by 185
Li, H., Sun, J., Du, J., Wang, F., Fang, R., Yu, C., Xiong, J., Chen, W., Lu, Z., & Liu, J. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13260 · Cited by 185
The role of diet and intestinal microbiota in the development of metabolic syndrome
Santos-Marcos, J. A., Perez-Jimenez, F., & Camargo, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.017 · Cited by 180
Powell, D. R., Smith, M., Greer, J., Harris, A., Zhao, S., DaCosta, C., Mseeh, F., Shadoan, M. K., Sands, A., Zambrowicz, B., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203364 · Cited by 184
Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3
Shimizu, H., Masujima, Y., Ushiroda, C., Mizushima, R., Taira, S., Ohue-Kitano, R., & Kimura, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-53242-x · Cited by 177
Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review
Rauf, A., Khalil, A. A., Rahman, U.-U., Khalid, A., Naz, S., Shariati, M. A., Rebezov, M., Urtecho, E. Z., de Albuquerque, R. D. D. G., Anwar, S., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895064 · Cited by 177
Gut microbiota: A new target for T2DM prevention and treatment
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., & Wei, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958218 · Cited by 176
Di, T., Chen, G., Sun, Y., Ou, S., Zeng, X., & Ye, H. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.10.040 · Cited by 181
The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
Pang, M. D., Goossens, G. H., & Blaak, E. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.598340 · Cited by 180
Resistant starch can improve insulin sensitivity independently of the gut microbiota
Bindels, L. B., Segura Munoz, R. R., Gomes-Neto, J. C., Mutemberezi, V., Martínez, I., Salazar, N., Cody, E. A., Quintero-Villegas, M. I., Kittana, H., de los Reyes-Gavilán, C. G., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0230-5 · Cited by 175
Jia, L., Li, D., Feng, N., Shamoon, M., Sun, Z., Ding, L., Zhang, H., Chen, W., Sun, J., & Chen, Y. Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-07335-0 · Cited by 179
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
Cai, J., Zhang, X.-J., Ji, Y.-X., Zhang, P., She, Z.-G., & Li, H. (2020) · Circulation Research · doi:10.1161/circresaha.119.316337 · Cited by 177
Anhê, F. F., Varin, T. V., Le Barz, M., Desjardins, Y., Levy, E., Roy, D., & Marette, A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0172-9 · Cited by 175
Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions
Hirabara, S. M., Gorjão, R., Vinolo, M. A., Rodrigues, A. C., Nachbar, R. T., & Curi, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/379024 · Cited by 178
Short-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177
Holmes, Z. C., Villa, M. M., Durand, H. K., Jiang, S., Dallow, E. P., Petrone, B. L., Silverman, J. D., Lin, P.-H., & David, L. A. (2022) · Microbiome · doi:10.1186/s40168-022-01307-x · Cited by 171
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
Cho, Y. M., Fujita, Y., & Kieffer, T. J. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170315 · Cited by 174
Blachier, F., Andriamihaja, M., Larraufie, P., Ahn, E., Lan, A., & Kim, E. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00261.2020 · Cited by 174
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 168
Martin-Gallausiaux, C., Larraufie, P., Jarry, A., Béguet-Crespel, F., Marinelli, L., Ledue, F., Reimann, F., Blottière, H. M., & Lapaque, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02838 · Cited by 167
Self-citationgutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites
Cheng, L., Qi, C., Yang, H., Lu, M., Cai, Y., Fu, T., Ren, J., Jin, Q., & Zhang, X. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab786 · Cited by 174
Fernandes, R., Viana, S. D., Nunes, S., & Reis, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 168
Free Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors
Offermanns, S. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135945 · Cited by 171
Free fatty acid receptors as therapeutic targets for the treatment of diabetes
Ichimura, A., Hasegawa, S., Kasubuchi, M., & Kimura, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00236 · Cited by 170
Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice
Vinolo, M. A. R., Rodrigues, H. G., Festuccia, W. T., Crisma, A. R., Alves, V. S., Martins, A. R., Amaral, C. L., Fiamoncini, J., Hirabara, S. M., Sato, F. T., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00053.2012 · Cited by 167
Harsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics
Torres, S., Fabersani, E., Marquez, A., & Gauffin-Cano, P. (2019) · European Journal of Nutrition · doi:10.1007/s00394-018-1790-2 · Cited by 170
Intersection of the Gut Microbiome and Circadian Rhythms in Metabolism
Frazier, K., & Chang, E. B. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.08.013 · Cited by 173
The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier
Tang, W., Zhu, H., Feng, Y., Guo, R., & Wan, D. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254403 · Cited by 161
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Rekha, K., Venkidasamy, B., Samynathan, R., Nagella, P., Rebezov, M., Khayrullin, M., Ponomarev, E., Bouyahya, A., Sarkar, T., Shariati, M. A., et al. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2124231 · Cited by 162
Gut microbiota and metabolic disorders: how prebiotic can work?
Delzenne, N. M., Neyrinck, A. M., & Cani, P. D. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004047 · Cited by 168
GPR41 and GPR43: From development to metabolic regulation
Lee, D., Kim, M.-T., & Han, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116735 · Cited by 189
Xiao, S., Liu, C., Chen, M., Zou, J., Zhang, Z., Cui, X., Jiang, S., Shang, E., Qian, D., & Duan, J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10174-w · Cited by 169
Gut microbiota and probiotics: Focus on diabetes mellitus
Bordalo Tonucci, L., Dos Santos, K. M. O., De Luces Fortes Ferreira, C. L., Ribeiro, S. M. R., De Oliveira, L. L., & Martino, H. S. D. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.934438 · Cited by 164
Role of free fatty acid receptors in the regulation of energy metabolism
Hara, T., Kashihara, D., Ichimura, A., Kimura, I., Tsujimoto, G., & Hirasawa, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.002 · Cited by 168
The interaction between the gut Microbiota and herbal medicines
An, X., Bao, Q., Di, S., Zhao, Y., Zhao, S., Zhang, H., Lian, F., & Tong, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109252 · Cited by 162
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X. (2024) · mBio · doi:10.1128/mbio.02032-23 · Cited by 150
Wang, L., Li, P., Tang, Z., Yan, X., & Feng, B. (2016) · Scientific Reports · doi:10.1038/srep33251 · Cited by 165
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Chidambaram, S. B., Rathipriya, A. G., Mahalakshmi, A. M., Sharma, S., Hediyal, T. A., Ray, B., Sunanda, T., Rungratanawanich, W., Kashyap, R. S., Qoronfleh, M. W., et al. (2022) · Cells · doi:10.3390/cells11071239 · Cited by 160
Wu, Z., Zhang, B., Chen, F., Xia, R., Zhu, D., Chen, B., Lin, A., Zheng, C., Hou, D., Li, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1089991 · Cited by 158
Gut microbiota–derived short-chain fatty acids and kidney diseases
Li, L., Ma, L., & Fu, P. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s150825 · Cited by 164
Visekruna, A., & Luu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703218 · Cited by 173
Metadata
- Authors
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M.
- Affiliations
- Addenbrooke's Hospital (GB)
- Takeda (United Kingdom) (GB)
- Corresponding author
- Reimann, Frank
- Gribble, Fiona M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 364-371
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266401
- OpenAlex
- W2168842536
- Cited by
- 2,404
- References
- 32
- Citations by year
- 2026: 266 · 2025: 233 · 2024: 203 · 2023: 183 · 2022: 245 · 2021: 205 · 2020: 215 · 2019: 151 · 2018: 158 · 2017: 120 · 2016: 132 · 2015: 103 · 2014: 92 · 2013: 65 · 2012: 27
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo
- Funders
- Wellcome Trust (084210/Z/07/Z, 088357/Z/09/Z, #WT084210, 088357, 088357/Z/09/A)
- European Commission (2007–2013, 266408)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, glucagon-like peptide-1, FFAR2, GPR43, GPR41, incretin secretion, gut microbiota, prebiotic fermentation, colonic epithelial cells, calcium signaling, glucose tolerance, diabetes treatment, Gq signaling
- MeSH terms
- Animals, Calcium, Colon, Fatty Acids, Volatile, Mice, Inbred C57BL, Signal Transduction, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.